Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200501047258N1
IRCT20200501047258N1
Recruiting
Phase 2

Investigation of the effects of COVID-19 convalescent plasma in acute respiratory distress syndrome due to COVID-19

Oroumia University of Medical Sciences0 sites120 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Oroumia University of Medical Sciences
Enrollment
120
Status
Recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Positive PCR test
  • •The life\-threatening disease is defined as respiratory failure
  • •respiratory frequency \= 30/min
  • •blood oxygen saturation \= 93%
  • •partial pressure of arterial oxygen to fraction of inspired oxygen ratio \< 300
  • •lung infiltrates \> 50% within 24 to 48 hours

Exclusion Criteria

  • •Hypersensitivity to blood or blood products
  • •Uncontrolled bacterial infection
  • •Disagreement

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A study on convalescence stage of COVID-19 patientsovel Coronavirus Pneumonia (COVID-19) rehalibilitation phase
ITMCTR2100004829Shijiazhuang Fifth Hospital
Not yet recruiting
Not Applicable
Effect of COVID - 19 pandemic researchers
CTRI/2020/07/026836Manipal Academy of Higher Education
Recruiting
Not Applicable
Prospective observational study of COVID-19 patients in the TOKUSHUKAI GROUPThe purpose of this study is to collect information of the clinical course of patients with COVID-19 treated at Tokushukai hospitals with and without antiviral drugs and to explore the clinical course in the acute phase, the frequency of severe disease, and frequency of post COVID-19 condition by the treatment, after adjusting by patient background including risk factor(s) and symptoms at the time of registration.
JPRN-UMIN000053506Shionogi &amp; Co., Ltd.30,000
Completed
Not Applicable
Observational study on the evaluation of COVID-19 prevention and subjects&#39; health status after SARS-CoV-2 vaccinatioCOVID-19
JPRN-UMIN000045107Shionogi &amp; Co., Ltd.829
Recruiting
Not Applicable
Reserch on patients with COVID-19 at Osaka Saiseikai Nakatsu HospitalCOVID-19
JPRN-UMIN000041102Osaka Saiseikai Nakatsu Hospital1,200